Takeda fortifies orexin potential with more Phase 3 datanews2026-06-15T16:00:59+00:00June 15th, 2026|Endpoints News|
Lilly puts its stamp at #EHA26 with Jaypirca combo data in CLL, first clinical data from Ajax buyoutnews2026-06-15T11:39:34+00:00June 15th, 2026|Endpoints News|
Merck brings Welireg-Keytruda combo to treat kidney cancernews2026-06-12T20:52:21+00:00June 12th, 2026|Endpoints News|
Amgen and the FDA want two different outcomes for Tavneos. What will patients do?news2026-06-12T17:57:23+00:00June 12th, 2026|Endpoints News|
Eli Lilly invests in startup Abridge for clinical trial recruitmentnews2026-06-12T17:38:48+00:00June 12th, 2026|Endpoints News|
Biopharma’s pay oddities of 2025: Executive perks and eccentricitiesnews2026-06-12T14:00:54+00:00June 12th, 2026|Endpoints News|
WuXi AppTec sues Pentagon in challenge over inclusion on Chinese military listnews2026-06-12T11:21:11+00:00June 12th, 2026|Endpoints News|
GSK took advantage of ASCO dip to get discount on Nuvalentnews2026-06-12T11:14:14+00:00June 12th, 2026|Endpoints News|
Drugmakers are turning to logistics providers as trade disruptions linger, DHL exec saysnews2026-06-11T15:30:23+00:00June 11th, 2026|Endpoints News|
Biopharma pay report: Top-paid CSOs, CMOs of 2025news2026-06-11T14:00:07+00:00June 11th, 2026|Endpoints News|
